Biologicznie aktywne peptydy pochodzące z białek mleka

• Autorzy: Darewicz M. , Iwaniak A. , Minkiewicz P.

Warianty tytułu

EN

Biologically active peptides derived from milk proteins

• Języki publikacji: PL

Abstrakty

EN

Milk proteins possess a wide range of nutritional and biological properties. They are used as a source of energy, amino acids, vitamins, and minerals which are needed for the growth and development of organisms. Milk proteins contain physiologically active peptides encrypted in the protein sequences. Peptides with biological activity are produced during gastrointestinal digestion or food processing and could play an important role in metabolic regulation and modulation. This suggests the potential use of biopeptides as nutraceuticals and ingredients of functional foods to promote health and reduce the risk of diseases. Milk-derived bioactive peptides were shown to have antihypertensive, antihrombotic, antimicrobial, antioxidative, opioid, mineral-binding properties and anticancer activities. In vitro and in vivo studies are currently being carried out to identify milk bioactive peptides as well as to study their bioavailability and molecular mechanisms of action. Milk as a traditional food product can serve as the example of a functional food and be relevant for health-promoting as well as health-preventing factors.

Słowa kluczowe

PL

mleko krowie; bialka mleka; peptydy bioaktywne; wchlanianie; transport; aktywnosc biologiczna; aktywnosc przeciwutleniajaca; aktywnosc przeciwnowotworowa; aktywnosc przeciwnadcisnieniowa; aktywnosc przeciwdrobnoustrojowa

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2014
• Tom: 70
• Numer: 06
• Opis fizyczny: s.348-352,bibliogr.

Twórcy

autor

Darewicz M.

• Katedra Biochemii Żywności, Wydział Nauk o Żywności, Uniwersytet Warmińsko-Mazurski w Olsztynie, ul.Oczapowskiego 2, 10-729 Olsztyn

autor

Iwaniak A.

• Katedra Biochemii Żywności, Wydział Nauk o Żywności, Uniwersytet Warmińsko-Mazurski w Olsztynie, ul.Oczapowskiego 2, 10-729 Olsztyn

autor

Minkiewicz P.

• Katedra Biochemii Żywności, Wydział Nauk o Żywności, Uniwersytet Warmińsko-Mazurski w Olsztynie, ul.Oczapowskiego 2, 10-729 Olsztyn

Bibliografia

• 1. Bhuyan B. J., Mugesh G.: Angiotensin converting enzyme inhibitors in the treatment of hypertension. Curr. Sci. 2011, 101, 881-887.
• 2. Brinkmann C. R., Thiel S., Otzen D. E.: Protein-fatty acid complexes: Biochemistry, biophysics and function. FEBS J. 2013, 280, 1733-1749.
• 3. Bütikofer U., Meyer J., Sieber R., Wlather B., Wechsler D.: Occurrence of the angiotensin-converting enzyme-inhibiting tripeptides Val-Pro-Pro and Ile-Pro-Pro in different cheese varieties of Swiss origin. J. Dairy Sci. 2008, 91, 29-38.
• 4. Clare D. A., Swaisgood H. E.: Bioactive milk peptides: A prospectus. J. Dairy Sci. 2000, 83, 1187-1195.
• 5. Cross K. J., Huq N. L., Reynolds E. C.: Casein phosphopeptides in oral health-chemistry and clinical applications. Curr. Pharm. Design 2007, 13, 793-800.
• 6. Darewicz M., Dziuba J., Dziuba M.: Functional properties and biological activities of bovine casein proteins and peptides. Pol. J. Food Nutr. Sci. 2006, 15, 1, 79-86.
• 7. Erdmann K., Cheung B. W. Y., Schröder H.: The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease. J. Nutr. Biochem. 2008, 19, 643-654.
• 8. FitzGerald R. J., Murray B. A.: Bioactive peptides and lactic fermentations. Int. J. Dairy Technol. 2006, 59, 118-125.
• 9. FitzGerald R. J., Murray B. A., Walsh D. J.: Hypotensive peptides from milk proteins. J. Nutr. 2004, 143, 980S-988S.
• 10. García-Montoya I. A., Cendón T. S., Arévalo-Gallegos S., Rascón-Cruz Q.: Lactoferrin a multiple bioactive protein: An overview. BBA – General Subjects 2012, 1820, 226-236.
• 11. Hartmann R., Meisel H.: Food-derived peptides with biological activity: from research to food applications. Curr. Opin. Biotechnol. 2007, 18, 163-169.
• 12. Hernández-Ledesma B., Quirós A., Amigo L., Recio I.: Identification of bioactive peptides after digestion of human milk and infant formula with pepsin and pancreatin. Int. Dairy J. 2007, 17, 42-49.
• 13. Iwaniak A, Dziuba J.: Animal and plant origin proteins as the precursors of peptides with ACE inhibitory activity. Proteins evaluation by means of in silico methods. Food Technol. Biotechnol. 2009, 47, 441-449.
• 14. Iwaniak. A., Minkiewicz P.: Proteins as the source of physiologically and functionally active peptides. Acta Sci. Pol. Technol. Aliment. 2007, 6, 5-15.
• 15. Jäkälä P., Vapaatalo H.: Antihypertensive peptides from milk proteins. Pharmaceuticals 2010, 3, 251-272.
• 16. Korhonen H., Pihlanto A.: Bioactive peptides: novel applications for milk proteins. App. Biotechnol. Food Sci. Policy 2003, 1, 133-144.
• 17. López-Exposito I., Recio I.: Protective effect of milk peptides: antibacterial and antitumor properties. Adv. Exp. Med. Biol. 2008, 606, 271-293.
• 18. Meisel H., FitzGerald R. J.: Opioid peptides encrypted in milk proteins. Brit. J. Nutr. 2000, 84, S27-S31.
• 19. Minkiewicz P., Dziuba J., Darewicz M., Iwaniak A., Dziuba M., Nałęcz D.: Food peptidomics. Food Technol. Biotechnol. 2008, 46, 1-10.
• 20. Möller N. P., Scholz-Ahrens K. E., Roos N., Schrezenmeir J.: Bioactive peptides and proteins from foods: indications for health effects. Eur. J. Nutr. 2008, 47, 171-182.
• 21. Noursadeghi M., Bickerstaff M. C., Herbert J., Moyes D., Cohen J., Pepys M. B.: Production of granulocyte colony-stimulating factor in the nonspecific acute phase response enhances host resistance to baterial infection. J. Immunol. 2002, 169, 913-919.
• 22. Pellegrini A.: Antimicrobial peptides from food proteins. Curr. Pharm. Des. 2003, 9, 1225-1238.
• 23. Power O., Jakeman P., FitzGerald R. J.: Antioxidative peptides: enzymatic production, in vitro and in vivo antioxidant activity and potential applications of milk-derived antioxidative peptides. Amino Acids 2013, 44, 797-820.
• 24. Pripp A. H., Isaksson T., Stepaniak L., Sørhaug T.: Quantitative structure activity relationship (QSAR) of ACE-inhibitory peptides derived from milk proteins. Eur. Food Res. Technol. 2004, 219, 579-583.
• 25. Ruiz-Giménez P., Salom J. B., Marcos J. F., Vallés S., Martínez-Maqueda D., Recio I., Torregrosa G., Alborch E., Manzanares P.: Antihypertensive effect of a bovine lactoferrin pepsin hydrolysate: Identification of novel active peptides. Food Chem. 2012, 13, 266-273.
• 26. Rutherfurd K. J., Gill H. S.: Peptides affecting coagulation. Brit. J. Nutr. 2000, 84, (Suppl. 1), S99-S102.
• 27. Sakaguchi M., Koseki M., Wakamatsu M., Matsumura E.: Effects of systemic administration of beta-casomorphin-5 on learning and memory in mice. Eur. J. Pharmacol. 2006, 530, 81-87.
• 28. Segura-Campos M., Chel-Guerrero L., Betancur-Ancona D., Hernandez-Escalante V. M.: Bioavailability of bioactive peptides. Food Rev. Int. 2011,27, 213-226.
• 29. Séverin S., Wenshui X.: Milk biologically active components as nutraceuticals: Review. Crit. Rev. Food Sci. Nutr. 2005, 45, 645-656.
• 30. Sienkiewicz-Szłapka E., Jarmołowska B., Krawczuk S., Kostyra E., Kostyra H., Bielikowicz K.: Transport of bovine milk-derived peptides across a Caco-2 monolayer. Int. Dairy J. 2009, 19, 252-257.
• 31. Thomä-Worringer C., Sørensen J., López-Fandiño R.: Health effects and technological features of caseinomacropeptide. Int. Dairy J. 2006, 16, 1324-1333.
• 32. Tuccari G., Barresi G.: Lactoferrin in human tumours: Immunohistochemical investigations during more than 25 years. BioMetals 2011, 24, 775-784.
• 33. Udenigwe C. C., Aluko R. E.: Food-protein derived bioactive peptides: Production, processing, and potential health benefits. J. Food Sci. 2012, 71, R11-R24.
• 34. Zhu X.-L., Watanbe K., Shiraishi K., Ueki T., Noda Y., Matsui T.: Identification of ACE-inhibitory peptides in salt-free soy sauce that are transportable across Caco-2 cell monolayers. Peptides 2008, 29, 338-344.
• 35. Zucht H. D., Raida M., Adermann K. J., Forssman W. G.: Casocidin-I: a casein-αs₂ derived peptide exhibits antibacterial activity. FEBS Lett. 1995, 372, 185-188.